Detalhe da pesquisa
1.
Organoid Modeling of the Tumor Immune Microenvironment.
Cell
; 175(7): 1972-1988.e16, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550791
2.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature
; 569(7757): 503-508, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31068700
3.
Tangent normalization for somatic copy-number inference in cancer genome analysis.
Bioinformatics
; 38(20): 4677-4686, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040167
4.
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Prostate
; 82(5): 584-597, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084050
5.
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
PLoS Genet
; 12(8): e1006242, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27494029
6.
SAMNetWeb: identifying condition-specific networks linking signaling and transcription.
Bioinformatics
; 31(7): 1124-6, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25414365
7.
Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer.
Clin Cancer Res
; 28(11): 2339-2348, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101884
8.
Patient-derived xenografts undergo mouse-specific tumor evolution.
Nat Genet
; 49(11): 1567-1575, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28991255
9.
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.
Cancer Discov
; 7(9): 973-983, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28515055
10.
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
Nat Commun
; 8(1): 1324, 2017 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29109393
11.
Integrated genetic and pharmacologic interrogation of rare cancers.
Nat Commun
; 7: 11987, 2016 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27329820
12.
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting.
Cancer Discov
; 6(8): 914-29, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27260156